小児,青少年,若年腫瘍学における"テククイティ": 人工知能とインマーシブ技術による不平等に対処する
Vidya Puthenpura1, Mary Hunter2, Asher M Marks1
1Section of Pediatric Hematology and Oncology, Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.
Pediatric blood & cancer
|August 29, 2025
まとめ
仮想現実 (VR) のような人工知能 (AI) やインマーシブテクノロジーは 小児と青年の腫瘍学における健康格差を減らすことができます これらのツールは 治療における不平等を解決し 若いがん患者の治療のアクセスと質を向上させます
科学分野:
- 腫瘍学
- 医療情報学
- デジタル・ヘルス
背景:
- 小児,青少年,若い成人 (AYA) の腫瘍学では,社会経済的地位,地理,人種,民族によって健康の格差が続いている.
- これらの要因は 脆弱な患者集団の 医療へのアクセスの不平等と 健康的な結果の悪化につながります
研究 の 目的:
- 子どものがんとAYAの健康上の不平等に対処するために,人工知能 (AI) とインマーシブ技術 (仮想現実/拡張現実 - VR/AR) の可能性を探求する.
- これらの技術が若いがん患者の生活の質を向上させ 医療の提供のギャップを埋める方法について検討する.
主な方法:
- 新興技術のレビュー,特にAIとVR/AR,およびがん治療におけるその応用.
- デジタル・ディバイドを含む従来の介護の障壁を克服する方法の分析
- 倫理とコストの課題を考慮して,公平な実施のための戦略の探索.
主要な成果:
- AIは診断の精度を向上させ,治療計画をパーソナライズし,患者のナビゲーションを支援する可能性を示しています.
- 浸透型技術 (VR/AR) は,心理的なサポート,痛み管理,リハビリテーション,教育を含む公平なサポートケアを提供しています.
- インターネットの普及により 恵まれない地域の人々に 届く機会が生まれています
結論:
- AIとインマーシブテクノロジーを統合することで 小児やAYAの患者にとって より包括的で効果的ながんケア環境を 作り出すことができます
- 背景に関係なく,これらのイノベーションがすべての患者に恩恵をもたらすようにするには,公平な実施戦略が不可欠です.
- デジタル・ディバイドや 倫理的な問題やコストの障壁を 解決することは 普及に不可欠です
関連する概念動画
Issues And Trends In Healthcare Delivery System
5.8K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.8K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


